Related Experiment Video
Updated: Nov 9, 2025

10:31
Three-dimensional Imaging and Analysis of Mitochondria within Human Intraepidermal Nerve Fibers
Published on: September 29, 2017
10.5K
Diabetic Encephalopathy Affecting Mitochondria and Axonal Transport Proteins
Maryam Eslami Gharaati1, Arezo Nahavandi1,2, Torandokht Baluchnejad Mojarad1
1Department of Physiology, School of Medicine, Iran University of Medical Science, Tehran, Iran.
Basic and Clinical Neuroscience
|April 14, 2021
Summary
Diabetic encephalopathy in rats is linked to mitochondrial dysfunction and altered axonal transport. Streptozotocin-induced diabetes increased KIF5b expression, impairing cognitive function and mitochondrial membrane potential.
Area of Science:
- Neuroscience
- Metabolic Disorders
- Mitochondrial Biology
Background:
- Diabetic encephalopathy involves cognitive and memory impairments linked to hippocampal changes.
- Mitochondrial diabetes (MD) combines diabetes with cognitive deficits due to mutant mitochondrial DNA.
- This study investigates the relationship between diabetic encephalopathy, mitochondrial dysfunction, and axonal transport protein expression.
Purpose of the Study:
- To explore the correlation between diabetic encephalopathy, mitochondrial dysfunction, and changes in axonal transport proteins (KIF5b, Dynein).
- To assess the impact of diabetes on cognitive function and hippocampal mitochondrial health in a rat model.
Main Methods:
- Twenty-four Wistar rats were divided into control, diabetic, and diabetic + insulin groups.
- Diabetes was induced using Streptozotocin (STZ); blood sugar, weight, and behavioral tests were monitored.
- Hippocampal gene expression of KIF5b and Dynein, and mitochondrial membrane potential (MMP) were analyzed.
Main Results:
- Diabetic rats exhibited impaired HgbA1c, insulin, FBS, and weight, along with cognitive deficits in behavioral tests.
- KIF5b mRNA expression was significantly increased in the hippocampus of diabetic rats.
- Abnormal mitochondrial membrane potential was observed in diabetic rats, correlating with KIF5b up-regulation.
Conclusions:
- Up-regulation of KIF5b mRNA in diabetic rat hippocampus contributes to abnormal axonal transport and decreased MMP.
- These mitochondrial dysfunctions are implicated in impaired cognitive function and diabetic encephalopathy.
- The findings highlight mitochondrial dysfunction as a key factor in diabetes-related cognitive decline.
Related Concept Videos
Electron Transport Chain: Complex I and II
16.5K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
16.5K
Lysosomal Hydrolases
4.2K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.2K
ATP Synthase: Mechanism
15.7K
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
15.7K
Alzheimer's Disease: Overview
1.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.0K

